Flovent Diskus (fluticasone propionate inhalation powder)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
July 2016
ADVERSE REACTIONS
Postmarketing Experience
Infections and Infestations: Esophageal candidiasis.
USE...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts